scholarly journals Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke

2017 ◽  
Vol 14 (7) ◽  
pp. 799 ◽  
Author(s):  
Stephanie Bell ◽  
Judith Dean ◽  
Charles Gilks ◽  
Mark Boyd ◽  
Lisa Fitzgerald ◽  
...  
Keyword(s):  
Harm Reduction ◽  
Feasibility Study ◽  
Study Protocol ◽  
People Living With Hiv ◽  
Tobacco Harm Reduction ◽  
Nicotine Replacement ◽  
Living With Hiv

scholarly journals Harm Reduction Outreach Services and Engagement of Chemically Dependent Homeless People Living with HIV/AIDS: An Analysis of Service Utilization Data to Evaluate Program Theory

2016 ◽  
Vol 23 (1) ◽  
pp. 26 ◽  
Author(s):  
Benjamin Shepard
Keyword(s):  
Health Care ◽  
Harm Reduction ◽  
Service Utilization ◽  
Access To Health Care ◽  
Homeless People ◽  
People Living With Hiv ◽  
Outreach Services ◽  
Low Threshold ◽  
Living With Hiv ◽  
Hiv Aids

This study examines service utilization patterns among a socially vulnerable population of homeless people living with HIV/AIDS and who have a history of chemical dependence, as they are engaged through outreach services. CitiWide Harm Reduction collaborates with Montefiore Medical Center to connect homeless people with health care through harm reduction outreach and low threshold medical services. Analysis of two cohorts – individuals engaged through harm reduction outreach and individuals who “walk-in” to engage in services at CitiWide Harm Reduction’s drop-in center – assesses the program’s theory that outreach engagement is a mediating variable increasing service utilization. These results demonstrate that low-threshold harm reduction outreach, a brand of outreach designed to reduce barriers to services, does increase access to health care and related services for a socially vulnerable, traditionally “hard-to-reach,” population. Harm reduction outreach is a valuable intervention for increasing service utilization among this highly marginalized group.

scholarly journals Mediators of the Relationship Between Nicotine Replacement Therapy and Smoking Abstinence Among People Living With HIV/AIDS

2009 ◽  
Vol 21 (3_supplement) ◽  
pp. 65-80 ◽  
Author(s):  
Cassandra A. Stanton ◽  
Elizabeth E. Lloyd-Richardson ◽  
George D. Papandonatos ◽  
Marcel A. de Dios ◽  
Raymond Niaura
Keyword(s):  
Replacement Therapy ◽  
Nicotine Replacement Therapy ◽  
People Living With Hiv ◽  
Smoking Abstinence ◽  
Nicotine Replacement ◽  
Living With Hiv ◽  
The Relationship ◽  
Hiv Aids

scholarly journals Tailored mHealth intervention for improving treatment adherence for people living with HIV in Iran (HamRaah): protocol for a feasibility study and randomised pilot trial with a nested realist evaluation

BMJ Open ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. e042296
Author(s):  
Vira Ameli ◽  
Jessica Haberer ◽  
Lora Sabin ◽  
Franziska Meinck ◽  
Jane Barlow ◽  
...  
Keyword(s):  
Feasibility Study ◽  
Viral Suppression ◽  
Pilot Trial ◽  
Ethics Committee ◽  
Realist Evaluation ◽  
Evaluation Framework ◽  
People Living With Hiv ◽  
Art Adherence ◽  
Explanatory Theory ◽  
Living With Hiv

IntroductionMiddle East and North Africa (MENA) has a rising rate of new HIV infections and AIDS-related mortality. Consistent adherence to antiretroviral therapy (ART) leads to viral suppression, preventing HIV transmission and treatment failure. mHealth interventions can improve ART adherence by providing tailored support and directing patients to existing healthcare services. HamRaah (Persian for ‘together-in-path’) is the first mHealth-based intervention in a MENA country and is designed to improve adherence through two-way mobile messaging for people recently diagnosed with HIV in Tehran, Iran. The objectives of this pilot randomised controlled trial (RCT) are to examine the feasibility, acceptability and preliminary effectiveness of HamRaah, and to develop an explanatory theory for any observed effects through a nested realist evaluation.MethodsA feasibility study and two-arm RCT of HamRaah, with an embedded realist evaluation will be conducted. Participants will be randomised 1:1 to HamRaah or routine care for a 6-month intervention. The initial effectiveness of HamRaah will be assessed through the primary outcome of self-reported ART adherence and several secondary outcomes: retention in care, CD4 count and viral suppression. A theory-driven realist evaluation framework will be used to develop an explanatory theory regarding what works, for whom, how and in what context.Ethics and disseminationThe study received ethical clearance from Tehran University of Medical Sciences Ethics Committee and Oxford Tropical Research Ethics Committee People living with HIV in Tehran and key country stakeholders in HIV policy and programming have been involved in the development of HamRaah and this pilot trial. Participants will provide informed consent prior to study enrolment. The results will be disseminated to all stakeholders and presented in peer-reviewed journal publications and conferences.Trial registration numberIRCT20100601004076N23; Pre-results.

Sign in / Sign up

Export Citation Format

Share Document